BTCC
/
BTCC Square
/
Global Cryptocurrency
/
Winklevoss-Backed Leap Therapeutics to Start Crypto Treasury
Winklevoss-Backed Leap Therapeutics to Start Crypto Treasury
18
1
BTCCSquare news:
Leap Therapeutics, a Nasdaq-listed biotechnology firm, has secured $58.88 million in a private investment round led by Winklevoss Capital. The funding will support the creation of a digital asset treasury strategy, marking a significant foray into crypto by a traditional biotech company.
The PIPE transaction involves issuing common stock and warrants at $0.61439 per unit, with closing expected by October 8, 2025. Winklevoss Capital gains two board seats, including the chairperson role, as part of the governance restructuring.
While primarily earmarked for crypto treasury formation, partial funds will advance Leap's clinical pipeline. The MOVE signals growing institutional interest in digital assets beyond financial sectors.
By:
